- Advertisement -spot_img
Home基金创新药ETF国泰(517110)收涨超4.2%,年内涨幅近60%,恒瑞医药与葛兰素史克达成协议提振创新药板块

创新药ETF国泰(517110)收涨超4.2%,年内涨幅近60%,恒瑞医药与葛兰素史克达成协议提振创新药板块

- Advertisement -spot_img

每日经济新闻

创新药ETF国泰(517110)收涨超4.2%,年内涨幅近60%,恒瑞医药与葛兰素史克达成协议提振创新药板块

转载自 每经网

- Advertisement -spot_img
- Advertisement -spot_img
Must Read
- Advertisement -spot_img
Related News
- Advertisement -spot_img